Literature DB >> 7306232

Preliminary criteria for clinical remission in rheumatoid arthritis.

R S Pinals, A T Masi, R A Larsen.   

Abstract

A study was conducted to develop criteria for clinical remission in rheumatoid arthritis (RA). Data were provided by 35 rheumatologists on 175 RA patients considered to be in complete remission (with or without antirheumatic therapy) and 169 RA patients in partial remission or with active disease. Six criteria yielded optimal discrimination: morning stiffness absent or not exceeding 15 minutes, no fatigue, no joint pain by history, no joint tenderness, no joint or tendon sheath swelling, and no elevation of erythrocyte sedimentation rate. In this study sample, the presence of five or more of these criteria in an individual patient yielded 72% sensitivity for clinical remission and 100% specificity in discriminating RA patients with active disease. In a population sample, it is estimated that the overall accuracy of these criteria would be more than 90% in RA patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306232     DOI: 10.1002/art.1780241012

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  151 in total

Review 1.  The treatment of rheumatoid arthritis: a review of recent clinical trials.

Authors:  T Mikuls; L Moreland
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

Review 2.  Clinical outcome measures in rheumatoid arthritis.

Authors:  P L van Riel; A M van Gestel
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

3.  Comparison of soluble adhesion molecules in juvenile idiopathic arthritis between the active and remission stages.

Authors:  C-Y Chen; C-H Tsao; L-S Ou; M-H Yang; M-L Kuo; J-L Huang
Journal:  Ann Rheum Dis       Date:  2002-02       Impact factor: 19.103

4.  Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis.

Authors:  M Boers; M T Nurmohamed; C J A Doelman; L R Lard; A C Verhoeven; A E Voskuyl; T W J Huizinga; R J van de Stadt; B A C Dijkmans; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

Review 5.  What should we hope to achieve when treating rheumatoid arthritis?

Authors:  D L Scott; T D Spector; T Pullar; B McConkey
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

Review 6.  Sulfasalazine: a review of its use in the management of rheumatoid arthritis.

Authors:  Greg L Plosker; Katherine F Croom
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Clinical, laboratory and genetic markers associated with erosions and remission in patients with early inflammatory arthritis: a prospective cohort study.

Authors:  A Stockman; B D Tait; R Wolfe; C A Brand; M J Rowley; M D Varney; R Buchbinder; K D Muirden
Journal:  Rheumatol Int       Date:  2005-09-07       Impact factor: 2.631

8.  Clinical assessment of disease activity in rheumatoid arthritis: evaluation of a functional test.

Authors:  A A Kalla; T J Kotze; O L Meyers; N D Parkyn
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

9.  Randomized trial of switching rheumatoid arthritis patients in remission with injectable gold to auranofin.

Authors:  P E Prete; J Zane; M Krailo; M Bulanowski
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

10.  Is hand bone mineral density a marker for hand function in patients with established rheumatoid arthritis? The correlation among bone mineral density of the hand, radiological findings and hand function.

Authors:  Beril Dogu; Banu Kuran; Figen Yilmaz; Ahmet Usen; Hulya Sirzai
Journal:  Clin Rheumatol       Date:  2013-04-16       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.